The Medicare GLP-1 Bridge vs. Manufacturer Savings Cards: Which Actually Applies to You
If you're Medicare-eligible, you may actually have two different discount paths available for GLP-1 medication: the new Medicare GLP-1 Bridge, and manufacturer savings cards. They don't work the same way, and for most Medicare patients, only one is realistically usable. Here's the comparison.
The Medicare GLP-1 Bridge
Launched July 1, 2026, this CMS demonstration program targets a $50/month copay for eligible Part D beneficiaries on participating plans, for FDA-approved brand-name medication. It requires Part D enrollment and plan participation — not every plan has opted in yet.
Manufacturer savings cards
Novo Nordisk and Eli Lilly's savings programs typically require commercial insurance to qualify for the best pricing tiers — Medicare and Medicaid patients are usually explicitly excluded from manufacturer savings card eligibility, since these programs are generally structured around commercial insurance copay assistance rules.
Why this matters if you're on Medicare
For most Medicare beneficiaries, manufacturer savings cards simply aren't an option — the Bridge program is the more realistic discount path, assuming your Part D plan participates. This isn't a close call between two similarly-available options; it's closer to Bridge-or-nothing for the manufacturer-discount route specifically.
Sesame Care From $44
Prescribes FDA-approved brand-name medications with transparent pricing — a straightforward option to pair with Medicare Bridge eligibility once confirmed.
The bottom line
If you're on Medicare, check your Part D plan's Bridge participation status first — that's the discount path actually built for you. Manufacturer savings cards are the better option for commercially-insured patients, not Medicare beneficiaries specifically.